journal article·2025-08-08

Triple-Enzyme Mimetic Flexible-Interlaced Ferromagnetic Porous-Organic-Polymer for Self-Adaptive Antibacterial Cascade Therapy via Microenvironment-Reprogramming and Photosensitizer-Aggregation-Suppression

Dandan Xu, Sue Cao, Weiwei Bian, Xiaoming Shi, Dong Zhang, Baolong Zhou, Kun Li, Yan Jiang, Yijun Liu, Yuyu Wang, Junjie Li, Xinkai Han

ACS Applied Polymer Materials· Volume 7· Issue 15
Publisher page

Abstract

The complex pathological microenvironment of infected wounds impedes antimicrobial efficacy while accelerating bacterial resistance. To overcome this, an oxygen-evolving polyphenol-based magnetic porous polymer (FcPor-POP) was engineered through the covalent conjugation of ferrocene-derived enzymatic units and photoactive polyphenol-porphyrin via phenolic-aldehyde condensation. The concurrently introducing antiquenching structural motifs, realized by flexible saturated carbon linkages, sandwich-like interleaved units, as well as a hydrogen-bond interlocked structure, effectively suppress photoactivity loss induced by π–π aggregation. The FcPor-POP system achieves adaptive antibacterial action through hierarchically coordinated spatiotemporal mechanisms. Pathological microenvironmental cues dynamically trigger enzymatic activity switching. Under acidic pH, the ferrocene units and in situ-formed Fe 3 O 4 nanoparticles exhibit peroxidase-like (POD) activity, converting H 2 O 2 to cytotoxic • OH (accelerated by photothermal heating). Upon H 2 O 2 depletion, oxidase-like (OXD) activity dominates, leveraging multivalent iron centers to produce O 2 •–, preserving enzyme-like antibacterial function. Targeted ROS delivery is enabled by phenolic hydroxyl groups that anchor to bacterial membranes via H-bonding, combined with rough surface topography enhancing physical adhesion. This minimizes the distance between ROS generation sites (Fe centers/photosensitizers) and bacterial targets, ensuring efficient membrane disruption by short-lived species. The polymer matrix orchestrates three cross-amplifying circuits. The catalase-like (CAT) activity decomposes H 2 O 2 into O 2, alleviating hypoxia while fueling the OXD and photodynamic therapy (PDT) in a self-reinforcing cycle. Photothermal cascades amplify all enzyme kinetics (POD/OXD/CAT) and directly damage pathogens. Microenvironment reprogramming occurs as in situ-formed Fe 3 O 4 consumes H + /H 2 O 2, elevating local pH to disrupt bacterial acid tolerance and reduce oxidative stress. This hierarchical coordination, where microenvironment sensing controls temporal enzyme switching, membrane targeting enables spatial ROS precision, and light-driven cascades (O 2 self-supply, PDT, PTT activation, and multienzyme synergy) optimize material/energy flow, establishes FcPor-POP as a dynamic therapeutic system with maximal antibacterial efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Affiliated Hospital of Shandong Second Medical University

Shandong Second Medical University

School of Pharmacy

Shandong Neptunus Galaxy Pharmaceutical Co., Ltd

Comprehensive Treatment Room Outpatient Department

The Fourth Medical Center of Chinese PLA General Hospital

School of Life Sciences and Technology

Funding

Natural Science Foundation of Shandong Province

References (72)

Show source-provided references
1. 10.1016/j.cej.2021.12943110.1016/j.cej.2021.129431 ↗
2. 10.1039/D0RA09739J10.1039/D0RA09739J ↗
3. 10.1007/s00203-023-03826-z10.1007/s00203-023-03826-z ↗
4. 10.1038/s41579-024-01035-z10.1038/s41579-024-01035-z ↗
5. 10.1016/j.mib.2013.06.01310.1016/j.mib.2013.06.013 ↗
6. 10.3390/ijms23211365510.3390/ijms232113655 ↗
7. 10.1002/adma.20241897810.1002/adma.202418978 ↗
8. 10.1016/j.cej.2022.13714710.1016/j.cej.2022.137147 ↗
9. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
10. 10.1002/anie.20170114610.1002/anie.201701146 ↗
11. 10.1039/D1BM00317H10.1039/D1BM00317H ↗
12. 10.1039/C6TB02249A10.1039/C6TB02249A ↗
13. 10.1016/j.jcis.2021.12.07110.1016/j.jcis.2021.12.071 ↗
14. 10.1002/adhm.20240160910.1002/adhm.202401609 ↗
15. 10.1021/acsami.9b0435110.1021/acsami.9b04351 ↗
16. 10.1021/acsami.4c0499410.1021/acsami.4c04994 ↗
17. 10.1002/wnan.176910.1002/wnan.1769 ↗
18. 10.1038/s41467-018-06164-710.1038/s41467-018-06164-7 ↗
19. 10.1016/j.biotechadv.2024.10837610.1016/j.biotechadv.2024.108376 ↗
20. 10.1002/wnan.197910.1002/wnan.1979 ↗
21. 10.1038/s41467-024-50094-610.1038/s41467-024-50094-6 ↗
22. 10.1038/s41598-024-60824-x10.1038/s41598-024-60824-x ↗
23. 10.3390/molecules2905103910.3390/molecules29051039 ↗
24. 10.1039/D1CS01011E10.1039/D1CS01011E ↗
25. 10.1016/j.cis.2024.10323310.1016/j.cis.2024.103233 ↗
26. 10.1016/j.dyepig.2021.10913610.1016/j.dyepig.2021.109136 ↗
27. 10.1002/anie.20240083810.1002/anie.202400838 ↗
28. 10.3390/pharmaceutics1303029610.3390/pharmaceutics13030296 ↗
29. 10.1016/j.jddst.2024.10540910.1016/j.jddst.2024.105409 ↗
30. 10.1002/adfm.20210598910.1002/adfm.202105989 ↗
31. 10.1039/c3ta11934c10.1039/c3ta11934c ↗
32. 10.1039/C4RA12834F10.1039/C4RA12834F ↗
33. 10.1016/j.apsusc.2021.14945310.1016/j.apsusc.2021.149453 ↗
34. 10.1016/j.fuel.2018.06.01010.1016/j.fuel.2018.06.010 ↗
35. 10.1002/smll.20230085710.1002/smll.202300857 ↗
36. 10.1007/s10570-010-9481-z10.1007/s10570-010-9481-z ↗
37. 10.1063/5.016070010.1063/5.0160700 ↗
38. 10.1021/acs.jpcb.2c0493910.1021/acs.jpcb.2c04939 ↗
39. 10.3390/ma1518623710.3390/ma15186237 ↗
40. 10.1021/acs.est.1c0108510.1021/acs.est.1c01085 ↗
41. 10.1016/j.jhazmat.2017.08.04710.1016/j.jhazmat.2017.08.047 ↗
42. 10.1016/j.jmbbm.2016.10.00910.1016/j.jmbbm.2016.10.009 ↗
43. 10.1016/j.jallcom.2019.15233710.1016/j.jallcom.2019.152337 ↗
44. 10.1039/D2TB01015A10.1039/D2TB01015A ↗
45. 10.1016/j.carbon.2019.02.03310.1016/j.carbon.2019.02.033 ↗
46. 10.1016/j.apsusc.2020.14534510.1016/j.apsusc.2020.145345 ↗
47. 10.1016/j.jcou.2019.05.01610.1016/j.jcou.2019.05.016 ↗
48. 10.1016/j.inoche.2023.11135510.1016/j.inoche.2023.111355 ↗
49. 10.1016/j.mtbio.2021.10019810.1016/j.mtbio.2021.100198 ↗
50. 10.1039/C7CS00522A10.1039/C7CS00522A ↗
51. 10.1002/cssc.20240082910.1002/cssc.202400829 ↗
52. 10.1039/D4DT00650J10.1039/D4DT00650J ↗
53. 10.1093/mtomcs/mfac07010.1093/mtomcs/mfac070 ↗
54. 10.1016/j.msec.2018.12.01010.1016/j.msec.2018.12.010 ↗
55. 10.1021/acs.inorgchem.3c0078210.1021/acs.inorgchem.3c00782 ↗
56. 10.1021/acsnano.4c1027710.1021/acsnano.4c10277 ↗
57. 10.1021/acsami.8b2248710.1021/acsami.8b22487 ↗
58. 10.3390/ma1408193310.3390/ma14081933 ↗
59. 10.1021/acsnano.4c1226110.1021/acsnano.4c12261 ↗
60. 10.1002/adhm.20240239310.1002/adhm.202402393 ↗
61. 10.1016/j.cej.2022.13785510.1016/j.cej.2022.137855 ↗
62. 10.1021/jacs.4c0253010.1021/jacs.4c02530 ↗
63. 10.3390/antiox1102024410.3390/antiox11020244 ↗
64. 10.1038/s41467-022-33098-y10.1038/s41467-022-33098-y ↗
65. 10.3390/molecules2720713610.3390/molecules27207136 ↗
66. 10.1039/D4MD00002A10.1039/D4MD00002A ↗
67. 10.3390/pharmaceutics1507189310.3390/pharmaceutics15071893 ↗
68. 10.3390/foods1207136110.3390/foods12071361 ↗
69. 10.1002/adhm.20210077510.1002/adhm.202100775 ↗
70. 10.1016/j.jmst.2023.04.00510.1016/j.jmst.2023.04.005 ↗
71. 10.1016/j.jcis.2018.05.02410.1016/j.jcis.2018.05.024 ↗
72. 10.1016/j.pdpdt.2022.10301110.1016/j.pdpdt.2022.103011 ↗